Poorly managed and wrong timing to release Investor...

First 14 Last

Share
Profile

Follow
Monster_User

86 Posts.

4

08/10/18

23:35

Post #: 36043413
Share

Poorly managed and wrong timing to release Investor presentation. Board need to resolve 249D before reaching out to potential investors.

Originally posted by Bear10 ↑

Originally posted by hurcorh
I emailed current ceo with questions and all I got back was 'will happily speak on the phone' which in my book means you can't trust my word and can't prove my word if it's not written down. No cred.

Whole board is responsible for the ridiculous spending that has happened over the past few years. They went too hard too early on pay packets when all focus should be on fda approval and increasing accuracy. Instead we've increased costs and accuracy on latest fda submission was one of the worst results we've seen. A larger team / advisory board and the product worsened..... Our only recovery is with Peta back onboard and removing current chairman imo
I had a good conversation with Peta about an alternative strategy for the company post Jack and given the dire capital situation. It was the ony crack of a smile I’ve had since this whole ruse went pear shaped. SH would jump on it. Company seems to has lost its way and it’s credibilty. Peta and her team implemented the program in my organization and she inspired me so much a group of us I invested as a result. I don’t know WTF has happened. My company has since pulled the program and asked MEB not to use their name since the Vital Conversation team quit.

Expand

MEB Price at posting: 5.8¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ASX Market Open: Aussie investors to power past concerns raised by Trump's tariff threats | November 27, 2024

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 24 more messages in this thread...

First 14 Last

Add MEB (ASX) to my watchlist

Poorly managed and wrong timing to release Investor...

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ASX Market Open: Aussie investors to power past concerns raised by Trump's tariff threats | November 27, 2024

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game